FPE-026

N/A

Report date: 2025/04/28 14:59:26

Base Information

Drug NameFPE-026

Drug Alias NameFPE-026

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionTumor-associated antigen modulatorsT cell surface glycoprotein CD3 modulatorsT-cell receptor modulators

TargetsTumor-associated antigenT cell surface glycoprotein CD3T-cell receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGuangdong Fapon Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Fapon Biopharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A